Inherited Retinal Degeneration Clinical Trials
2 recruiting trials for Inherited Retinal Degeneration. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Inherited Retinal Degeneration clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Science Corporation (1), Jaeb Center for Health Research (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is PRIMA Products (device, 1 trial).
Track Inherited Retinal Degeneration trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration
The objective of this study is to evaluate the efficacy and safety of the PRIMA Products in participants with inherited retinal degeneration affecting the macula (including but...
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare...
This is an international, multicenter study with two components: Registry * A standardized genetic screening and a prospective, standardized, cross-sectional clinical data...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Inherited Retinal Degeneration, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Inherited Retinal Degeneration, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Inherited Retinal Degeneration, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.